Skip to main content
New Relic logo

New Relic

Security and trust center evidence

newrelic.comDevOps and observabilityLast verified 17 Sep 2026

Summary

New Relic has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, New Relic is listed in the FedRAMP registry as FedRAMP Authorized, with authorization dating from 2 Mar 2020 and audited by Schellman Compliance, LLC. As of 17 Sep 2026, New Relic is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 16 Jun 2020. As of 17 Sep 2026, New Relic is listed in the EU-US Data Privacy Framework registry as active, covering UK Extension, SW-US, and EU-US Certifications, issued 8 Nov 2016 and expiring 12 Aug 2027. As of 17 Sep 2026, no public evidence found for SOC 2. As of 17 Sep 2026, no public evidence found for HIPAA compliance or a stated BAA.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized (issued 2 Mar 2020, auditor Schellman Compliance, LLC) - as of 17 Sep 2026
  • CSA STAR: listed in CSA STAR registry at Level 1 self-assessment (CAIQ), issued 16 Jun 2020 - as of 17 Sep 2026
  • EU-US Data Privacy Framework: listed as active (UK Extension, SW-US, EU-US Certifications), issued 8 Nov 2016, expires 12 Aug 2027 - as of 17 Sep 2026

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among devops and observability vendors

3verified rows

Category median 1, across 90 indexed devops and observability vendors. New Relic has more verified rows than 100 percent of them.

apminfrastructuremonitoringobservability

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the DevOps and observability category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.